皓宸医疗科技股份有限公司 2025 年半年度非经营性资金占用及其他关联资金往来情况汇总表 单位:万元 | 非经营性资金占用 | 资金占用 | 占用方与上 | 上市公司 | 年 2025 | 年 月占 2025 1-6 | | 年 月 2025 1-6 | | 年 2025 1-6 | | 年 月 2025 6 | 占用形 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 方名称 | 市公司的关 | 核算的会 | 期初占用 | 用累计发生金额 | | 占用资金的利 | | 月偿还累计 | 30 | 日占用资 | 成原因 | 占用性质 | | | | 联关系 | 计科目 | 资金余额 | （不含利息） | | 息（如有） | | 发生金额 | | 金余额 | | | | 控股股东、实际控制 | | | | | | | | | | | | | | | 人及其附属企业 | | | | | | | | | | | | | 非经营性占用 | | 小计 | | | | | | | | | ...

皓宸医疗科技股份有限公司 2025 年半年度财务报告 皓宸医疗科技股份有限公司 2025 年半年度财务报告 2025 年 08 月 1 皓宸医疗科技股份有限公司 2025 年半年度财务报告 一、审计报告 半年度报告是否经过审计 □是 否 公司半年度财务报告未经审计。 二、财务报表 财务附注中报表的单位为：元 1、合并资产负债表 编制单位：皓宸医疗科技股份有限公司 2025 年 06 月 30 日 单位：元 | 项目 | 期末余额 | 期初余额 | | --- | --- | --- | | 流动资产： | | | | 货币资金 | 111,862,603.68 | 147,693,180.87 | | 结算备付金 | | | | 拆出资金 | | | | 交易性金融资产 | | | | 衍生金融资产 | | | | 应收票据 | 4,443,525.52 | 9,041,164.44 | | 应收账款 | 27,438,643.26 | 39,169,433.88 | | 应收款项融资 | | | | 预付款项 | 17,400,007.01 | 6,954,032.08 | | 应收保费 | | | | 应 ...

证券代码：002622 证券简称：皓宸医疗 公告编号：2025-019 皓宸医疗科技股份有限公司 1、《皓宸医疗科技股份有限公司第五届监事会第十五次会议决议》。 皓宸医疗科技股份有限公司（以下简称"公司"）第五届监事会第十五次会 议于 2025 年 8 月 17 日以电子邮件的形式发出会议通知，会议于 2025 年 8 月 28 日上午 11:00 以现场结合通讯表决方式召开。本次会议由监事会主席刘月先生主 持，会议应参加表决监事 3 人，实际参加表决监事 3 人。本次会议的内容以及召 集、召开的方式、程序均符合《公司法》和《公司章程》的规定。 与会监事经认真审议，通过如下议案： 一、审议通过《关于 2025 年半年度报告全文及摘要的议案》 表决结果：同意 3 票，反对 0 票，弃权 0 票； 表决结果：通过。 经审核，监事会认为董事会编制和审核公司 2025 年半年度报告的程序符合 法律、行政法规和中国证监会的规定，报告内容真实、准确、完整地反映了上市 公司的实际情况，不存在任何虚假记载、误导性陈述或者重大遗漏。 公司《2025 年半年度报告全文》具体内容详见公司指定信息披露网站巨潮 资讯网（www.cni ...

表决情况：同意 7 票，反对 0 票，弃权 0 票； 表决结果：通过。 本议案已经公司审计委员会审议并取得了明确同意的意见。 证券代码：002622 证券简称：皓宸医疗 公告编号：2025-018 皓宸医疗科技股份有限公司 第五届董事会第十五次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 皓宸医疗科技股份有限公司（以下简称"公司"）第五届董事会第十五次会 议于 2025 年 8 月 28 日上午 10:00 以现场结合通讯表决方式召开。召开本次会议 的通知已于 2025 年 8 月 17 日以电话、电子邮件等方式通知了各位董事。本次会 议由董事长陆璐女士主持，会议应参加表决董事 7 名，实际参加表决董事 7 名。 此次会议的召集、召开与表决程序符合《中华人民共和国公司法》和《公司章程》 及相关法律、法规的规定，合法有效。 与会董事经认真审议，通过如下议案： 一、审议通过《关于 2025 年半年度报告全文及摘要的议案》 1、《皓宸医疗科技股份有限公司第五届董事会第十五次会议决议》。 特此公告。 皓宸医疗科技股份有限公司董事会 二〇二五年八月二十八 ...

皓宸医疗科技股份有限公司 2025 年半年度报告全文 皓宸医疗科技股份有限公司 2025 年半年度报告 2025 年 8 月 所有董事均已出席了审议本次半年报的董事会会议。 半年度报告中所涉及未来的经营计划和经营目标，并不代表公司的盈利 预测，也不构成公司对投资者的实质承诺，能否实现取决于市场状况变化等 多种因素，存在不确定性，请投资者注意投资风险。 公司在经营中可能存在的风险因素内容已在本报告"第三节 管理层讨论 与分析"之"十、公司面临的风险和应对措施"部分予以描述，敬请投资者 仔细阅读并注意风险。 公司计划不派发现金红利，不送红股，不以公积金转增股本。 2 1 皓宸医疗科技股份有限公司 2025 年半年度报告全文 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容 的真实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担 个别和连带的法律责任。 公司负责人陆璐、主管会计工作负责人邓强及会计机构负责人(会计主管 人员)王延肖声明：保证本半年度报告中财务报告的真实、准确、完整。 | | . | | | --- | --- | --- | | | 4 | | ...

Market Overview - On August 27, the medical services sector declined by 2.14%, with Haitai Biological leading the drop [1] - The Shanghai Composite Index closed at 3800.35, down 1.76%, while the Shenzhen Component Index closed at 12295.07, down 1.43% [1] Stock Performance - Notable gainers in the medical services sector included: - Digital Human: Closed at 17.23, up 12.84% with a trading volume of 200,800 shares and a turnover of 355 million [1] - Nanmo Biology: Closed at 62.11, up 8.34% with a trading volume of 41,300 shares and a turnover of 250 million [1] - Dian Diagnostics: Closed at 17.49, up 5.81% with a trading volume of 813,500 shares and a turnover of 1.467 billion [1] - Major decliners included: - Haitai Biological: Closed at 51.28, down 6.87% with a trading volume of 128,800 shares and a turnover of 684 million [2] - Hongbo Pharmaceutical: Closed at 37.93, down 5.79% with a trading volume of 125,600 shares and a turnover of 498 million [2] - Huacheng Medical: Closed at 3.78, down 5.74% with a trading volume of 843,900 shares and a turnover of 328 million [2] Capital Flow - The medical services sector experienced a net outflow of 1.677 billion from institutional investors, while retail investors saw a net inflow of 951 million [2][3] - Key stocks with significant capital flow included: - Jinyu Medical: Net inflow of 120 million from institutional investors, but a net outflow of 79 million from retail investors [3] - Huada Gene: Net inflow of 107 million from institutional investors, with outflows from both retail and speculative investors [3] - Dian Diagnostics: Net inflow of 65.5 million from institutional investors, with outflows from speculative and retail investors [3]

Company Overview - Haochen Medical's stock price closed at 4.01 yuan on August 26, down 0.09 yuan, a decline of 2.20% from the previous trading day [1] - The company operates in the medical services sector, with concepts including medical beauty and smart grid [1] - Haochen Medical has a total market capitalization of 3.368 billion yuan, with circulating market value equal to total market value [1] Stock Performance - On August 26, the stock opened at 4.13 yuan, reached a high of 4.17 yuan, and a low of 4.01 yuan, with a trading volume of 793,867 hands and a transaction amount of 323 million yuan [1] - During the early trading session, the stock experienced a rapid rebound, increasing over 2% within 5 minutes, with a price of 4.13 yuan at 9:35 AM and a transaction amount of 34.93 million yuan [1] Capital Flow - On August 26, there was a net outflow of 2.1781 million yuan from the main funds, accounting for 0.06% of the circulating market value [1] - Over the past five trading days, the cumulative net inflow of main funds was 204.419 million yuan, representing 6.07% of the circulating market value [1]

Group 1 - The stock of Haocen Medical (002622) closed at 4.21 yuan on August 22, 2025, with a 9.92% increase, reaching the daily limit [1][2] - The trading volume for Haocen Medical on the same day was 1.4424 million hands, with a total transaction amount of 585 million yuan [1][2] - The closing order funds amounted to 73.0896 million yuan, representing 2.07% of its circulating market value [1][2] Group 2 - At 13:33, the stock reached its daily limit and closed at 4.21 yuan without being opened again [2] - The net inflow of main funds was 116 million yuan, while retail funds showed a net outflow of 33.2009 million yuan [2] - The net outflow of speculative funds was 82.7291 million yuan [2]

Market Performance - On August 22, the medical services sector rose by 1.29%, with Berry Genomics leading the gains [1] - The Shanghai Composite Index closed at 3825.76, up 1.45%, while the Shenzhen Component Index closed at 12166.06, up 2.07% [1] Top Gainers in Medical Services - Berry Genomics (000710) closed at 15.79, up 10.03% with a trading volume of 749,900 shares and a turnover of 1.153 billion yuan [1] - Haochen Medical (002622) closed at 4.21, up 9.92% with a trading volume of 1.4424 million shares and a turnover of 585 million yuan [1] - Golden Domain Medical (603882) closed at 11, up 4.02% with a trading volume of 148,600 shares and a turnover of 461 million yuan [1] Top Losers in Medical Services - Boji Pharmaceutical (300404) closed at 11.37, down 5.09% with a trading volume of 490,800 shares and a turnover of 557 million yuan [2] - ST Shenghua (000504) closed at 9.79, down 3.83% with a trading volume of 85,800 shares and a turnover of 84.73 million yuan [2] - Chengda Pharmaceutical (301201) closed at 30.34, down 3.38% with a trading volume of 104,000 shares and a turnover of 320 million yuan [2] Capital Flow Analysis - The medical services sector experienced a net outflow of 153 million yuan from institutional investors, while retail investors saw a net inflow of 246 million yuan [2][3] - Berry Genomics had a net inflow of 468 million yuan from institutional investors, but a net outflow of 214 million yuan from speculative funds [3] - Haochen Medical saw a net inflow of 116 million yuan from institutional investors, with a net outflow of 82.73 million yuan from speculative funds [3]

Group 1 - The core viewpoint of the news is that Haocen Medical has experienced a significant stock price increase, reaching a limit up of 9.92% on August 22, with a trading price of 4.21 yuan per share and a total market capitalization of 3.536 billion yuan [1] - Haocen Medical is primarily engaged in oral medical services and industrial manufacturing, with a focus on the research and innovation of permanent magnet switch products [1] - The company was listed on the Shenzhen Stock Exchange in 2011 and acquired a controlling stake in Guangdong Delun Medical Group in 2021 [1] Group 2 - As of March 31, Haocen Medical had 54,000 shareholders, with an average of 15,500 circulating shares per shareholder [2] - For the first quarter of 2025, Haocen Medical reported operating revenue of 143 million yuan, a year-on-year decrease of 12.58%, and a net profit attributable to shareholders of -12.2146 million yuan, a year-on-year decrease of 167.13% [2]